Collegium Pharmaceutical
COLL
eBay
EBAY
Halozyme Therapeutics
HALO
SilverCrest Metals
SILV
Workday
WDAY
(Q3)Sep 30, 2008 | (Q2)Jun 30, 2008 | (Q1)Mar 30, 2008 | (FY)Dec 31, 2007 | (Q4)Dec 31, 2007 | (Q3)Sep 30, 2007 | (Q2)Jun 30, 2007 | (Q1)Mar 30, 2007 | (FY)Dec 31, 2006 | (Q4)Dec 31, 2006 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | ||||||||||
Cost of revenue | ||||||||||
Gross profit | ||||||||||
Operating expense | -19.56%2.24M | 116.55%476.77K | -65.75%876.35K | -15.24%9.55M | -63.44%1.32M | 45.03%2.79M | -174.67%-2.88M | 39.75%2.56M | 264.93%11.27M | 3.61M |
Selling and administrative expenses | -19.56%2.24M | -83.45%476.77K | -65.75%876.35K | -22.23%8.76M | -85.26%531.81K | 45.03%2.79M | -25.33%2.88M | 39.75%2.56M | 264.93%11.27M | --3.61M |
Other operating expenses | ---- | ---- | ---- | --787.17K | ---- | ---- | ---5.76M | ---- | ---- | ---- |
Operating profit | 19.56%-2.24M | -116.55%-476.77K | 65.75%-876.35K | 15.24%-9.55M | 63.44%-1.32M | -45.03%-2.79M | 174.67%2.88M | -39.75%-2.56M | -264.93%-11.27M | -3.61M |
Net non-operating interest income expense | ||||||||||
Other net income (expense) | -107.34%-9.01K | -13.97K | -9,312.52%-659.43K | -782.14K | 122.7K | 7.16K | ||||
Special income (charges) | ---- | -107.34%-9.01K | ---13.97K | -9,312.52%-659.43K | ---782.14K | ---- | --122.7K | ---- | --7.16K | ---- |
Income before tax | ||||||||||
Income tax | ||||||||||
Net income | 17.48%-2.28M | 81.09%-515.22K | 63.55%-914.61K | 16.33%-9.3M | 63.05%-1.3M | -45.95%-2.77M | 28.95%-2.73M | -37.97%-2.51M | -260.73%-11.12M | -3.52M |
Net income continuous Operations | 17.48%-2.28M | 81.09%-515.22K | 63.55%-914.61K | 16.33%-9.3M | 63.05%-1.3M | -45.95%-2.77M | 28.95%-2.73M | -37.97%-2.51M | -260.73%-11.12M | ---3.52M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 17.48%-2.28M | 81.09%-515.22K | 63.55%-914.61K | 16.33%-9.3M | 63.05%-1.3M | -45.95%-2.77M | 28.95%-2.73M | -37.97%-2.51M | -260.73%-11.12M | -3.52M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 17.48%-2.28M | 81.09%-515.22K | 63.55%-914.61K | 16.33%-9.3M | 63.05%-1.3M | -45.95%-2.77M | 28.95%-2.73M | -37.97%-2.51M | -260.73%-11.12M | -3.52M |
Basic earnings per share | 10.00%-0.18 | 83.33%-0.04 | 50.00%-0.1 | 27.27%-0.8 | 66.67%-0.1 | 0.00%-0.2 | 40.00%-0.24 | 0.00%-0.2 | -120.00%-1.1 | -0.3 |
Diluted earnings per share | 10.00%-0.18 | 83.33%-0.04 | 50.00%-0.1 | 27.27%-0.8 | 66.67%-0.1 | 0.00%-0.2 | 40.00%-0.24 | 0.00%-0.2 | -120.00%-1.1 | -0.3 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |